Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2453 | 2020 |
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2139 | 2020 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 441 | 2021 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 333 | 2021 |
Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 222 | 2022 |
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease? V Sancho-Shimizu, P Brodin, A Cobat, CM Biggs, J Toubiana, CL Lucas, ... Journal of Experimental Medicine 218 (6), e20210446, 2021 | 138 | 2021 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
Vaccination in Primary Immunodeficiency Disorders A Sobh, FA Bonilla J ALLERGY CLIN IMMUNOL PRACT 4 (6), 1066-1075, 2016 | 127 | 2016 |
Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2) PY Lee, ES Kellner, Y Huang, E Furutani, Z Huang, W Bainter, ... Journal of allergy and clinical immunology 145 (6), 1664-1672. e10, 2020 | 119 | 2020 |
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 92 | 2021 |
A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 91 | 2022 |
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children D Lee, J Le Pen, A Yatim, B Dong, Y Aquino, M Ogishi, R Pescarmona, ... Science 379 (6632), eabo3627, 2022 | 70 | 2022 |
Consensus Middle East and North Africa Registry on inborn errors of immunity A Aghamohammadi, N Rezaei, R Yazdani, S Delavari, N Kutukculer, ... Journal of clinical immunology 41 (6), 1339-1351, 2021 | 43 | 2021 |
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 D Matuozzo, E Talouarn, A Marchal, P Zhang, J Manry, Y Seeleuthner, ... Genome medicine 15 (1), 22, 2023 | 38 | 2023 |
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues M D’Antonio, JP Nguyen, TD Arthur, H Matsui, BM Neale, M Daly, ... Cell reports 37 (7), 2021 | 27 | 2021 |
The Middle East and North Africa diagnosis and management guidelines for inborn errors of immunity S Baris, H Abolhassani, MJ Massaad, M Al-Nesf, Z Chavoshzadeh, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (1), 158-180. e11, 2023 | 23 | 2023 |
Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency SH Lum, S Selvarajah, A Deya-Martinez, P McNaughton, A Sobh, ... Journal of Allergy and Clinical Immunology 146 (2), 406-416, 2020 | 22 | 2020 |
Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation A Sobh, J Chou, L Schneider, RS Geha, MJ Massaad Journal of Allergy and Clinical Immunology 138 (1), 297-299, 2016 | 19 | 2016 |
Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly A Sobh, E Crestani, B Cangemi, J Kane, J Chou, SY Pai, LD Notarangelo, ... Journal of Allergy and Clinical Immunology 137 (1), 324-327. e2, 2016 | 17 | 2016 |
DOCK8 and STAT3 dependent inhibition of IgE isotype switching by TLR9 ligation in human B cells MJ Massaad, B Cangemi, W Al-Herz, G LeFranc, A Freeman, S Baxi, ... Clinical immunology (Orlando, Fla.) 183, 263-265, 2017 | 16 | 2017 |